Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. - Wikidata - wikimedia - TriplyDB

Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.

Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.

http://www.wikidata.org/entity/Q38420904

about

Managing atrial fibrillation in the very elderly patient: challenges and solutions Perioperative atrial fibrillation: a systematic review of evolving therapeutic options in pharmacologic and procedural management Hybrid Imaging During Transcatheter Structural Heart Interventions Ablation of Atrial Fibrillation in Combination with Left Atrial Appendage Occlusion in A Single Procedure. Rationale and Technique Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility Atrial Fibrillation and Risk of Dementia/Cognitive Decline Cardiac Plug I and Amulet Devices: Left Atrial Appendage Closure for Stroke Prophylaxis in Atrial Fibrillation Anticoagulation in Heart Failure: a Review Cardioembolic Stroke.Anticoagulation for Atrial Fibrillation in Patients with Cerebral Microbleeds.Cerebral Microhemorrhages: Significance, Associations, Diagnosis, and Treatment.Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies.Commonly Used Dietary Supplements on Coagulation Function during Surgery How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion Atrial fibrillation ablation and left appendage closure in heart failure patients Left Atrial Appendage Closure Guided by Integrated Echocardiography and Fluoroscopy Imaging Reduces Radiation Exposure.Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation.Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials.Left Atrial Appendage Function and Stroke Risk Anticoagulation in Heart Failure: a Review.Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience.Regional function analysis of left atrial appendage using motion estimation CT and risk of stroke in patients with atrial fibrillation Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry.Five years of keeping a watch on the left atrial appendage-how has the WATCHMAN fared?Roles of real-time three-dimensional transesophageal echocardiography in peri-operation of transcatheter left atrial appendage closure Left atrial appendage occlusion: A better alternative to anticoagulation?New approaches to managing nonvalvular atrial fibrillation: what are the thromboembolic implications?An overview of left atrial appendage occlusion devices.Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A professional societal overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.Role of Endovascular Closure of the Left Atrial Appendage in Stroke Prevention for Atrial Fibrillation.Interventional and surgical occlusion of the left atrial appendage.2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and training.Recent Advances in Stroke Prevention in Patients with Atrial Fibrillation and End-Stage Renal Disease.Tailored treatment strategies: a new approach for modern management of atrial fibrillation.Influence of the CYP4F2 polymorphism on the risk of hemorrhagic complications in coumarin-treated patients.Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges.Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.

P2860

Q26775877-A50BCFD3-DB2F-4DDB-8C1B-98C647B545AA Q26781769-191C1BE8-3597-4BCE-BA0B-BA17537AF2F8 Q26801925-ED3EB1C7-2768-4CFA-B293-C9448B83308F Q28068321-0AD75891-80F5-426E-9BA6-5C2E505E1361 Q28071688-2984FC7A-81BC-4F11-A3E5-90C11EED866F Q28074311-E80E484F-831C-4619-9654-4A061B2DEBD0 Q28081426-A87E1B68-E019-43AA-A686-CE22BB3A3316 Q28087068-98CA2C76-FA88-493E-B45C-840E2B660BFD Q30238631-6BAAE7BB-1ACC-4516-BB04-13F7AE094BE7 Q30975560-B1836C44-648D-47B1-A70D-DFC1E012E61C Q31108748-52AD4D22-B812-4632-9201-FD12AA1B0C54 Q31122441-AEF5BA73-B1F3-4145-8BDE-1415E8B9318C Q34517159-EC741226-7E5A-479C-9DD4-C0A887FC5569 Q35214488-35EF8215-F5D7-4DF4-9085-9D46C96E1AC8 Q35755766-590CC452-AE00-4E46-9171-D852C569A737 Q35806330-CDCE80EC-DE38-41C1-BE5C-57497EEF1992 Q35877931-9512A7B0-F041-4D4E-9787-C48C4297A8F4 Q36153857-230F4D87-D83D-4009-8102-134A5E7C9603 Q36319590-F30EFAB1-4F37-4F7A-ADB1-04EFF2E92990 Q36381170-919D0F51-26D9-4239-85B5-C0D9054C9FA2 Q36773643-EE4C7528-6B48-464E-9088-C12BA37E1C94 Q37002984-9A6564BE-E644-46BA-8777-E6BCAA56DAC4 Q37015495-13E08F85-07CC-4CD5-9E53-0664CDEDD886 Q37200456-A51F598D-C764-4394-9F11-D81996DCA8F5 Q37581151-D41C5418-3BBB-419B-B16B-13A7429EF7E1 Q37619507-60DE1BE1-22F1-4081-9B6D-B123ED12BA9F Q37670952-F3F1DA33-AA42-4FE2-A59F-533D84A72CDF Q38343151-D53B3DBE-C2F5-4299-BF0A-91EA5EBCA96D Q38366102-2617489E-5916-4D5C-A0AC-191C33D48C17 Q38526411-ED5EC2FC-1E22-4B32-8898-A8EE539852BB Q38563391-4EA90620-D44A-4329-A890-004720A12E48 Q38593072-D987CFCC-D892-427C-AD26-B8558EFE754E Q38630969-19F45A0E-B057-4AF3-AF8A-DEC7E3BCE939 Q38647787-B19C93F7-9F5C-4566-8684-FBF49617237C Q38656357-5355504E-0273-408F-828D-5FFF76373A4B Q38665579-C57831C6-A7BA-41E3-8BB7-DE9E2BFF2A1C Q38780134-E9004433-F249-4D10-949E-E08A7B6DA38A Q38799910-AD7FDD3A-C9EC-4963-9C8C-A96A321D5614 Q38851232-36E609F1-B7D1-48F2-9525-2CDAAEF22996 Q38970641-7C8C287F-2A49-4575-B51A-7F5F30E19AA2

P2860

Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.

http://www.wikidata.org/entity/Q38420904

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Percutaneous left atrial appen ...... : a randomized clinical trial.

@en

type

label

Percutaneous left atrial appen ...... : a randomized clinical trial.

@en

prefLabel

Percutaneous left atrial appen ...... : a randomized clinical trial.

@en

P1433

Q38420904-9FBEFDFC-5EA1-495B-BBDC-27551B8485F8

P1476

Q38420904-6515D587-062E-4A27-BC7D-B95D8968C115

P2093

Q38420904-094F5FB0-26E3-4CBC-8010-8DAE1F450B09

Q38420904-21EB01BB-8FA8-463F-8651-530E832E2A95

Q38420904-25D253E4-F9FD-440A-9A1A-411B316FA2AA

Q38420904-3AE3D19E-96AE-41ED-8FB1-9681685730D9

Q38420904-4184669E-17D1-44BE-83C4-BCC1A0AE7500

Q38420904-732A4351-E28A-4E14-8FAF-5BA8C906B211

Q38420904-80FF3308-F27E-4081-A019-70C9B9DC5637

Q38420904-8853ACAF-2525-4298-AA66-CEDB1A5E9BD9

Q38420904-94D2BCA2-0582-45D7-8E0E-E945FCD310D4

Q38420904-A73B1AE2-F849-4C05-A196-E2C8C16328B8

P304

Q38420904-B8CFACAD-7436-4F7A-9C77-C3D87EC81083

P31

Q38420904-361A12C8-C912-4F8E-A942-5C942EE23A9F

P356

Q38420904-389A28E1-256E-4E15-B173-068517800EC9

P407

Q38420904-75F606B7-FD11-41E4-A182-DDEA9BEAB23E

P433

Q38420904-B380C391-AA52-4ED2-A647-801ED9B890F7

P478

Q38420904-57C1DA85-ECC6-4509-B501-8D996E2DCED9

P50

Q38420904-0A32A890-5F12-4C5A-852E-1719FE97390B

P577

Q38420904-8918A2C3-E29F-48D1-B769-D2A1DBADD9A2

P698

Q38420904-B5FAC36A-7F1F-4CA0-BE62-7752CFFF0C77

P921

Q38420904-56E66574-A80A-47F2-9E22-55D8017459C8

P356

JAMA.2014.15192

P1433

Journal of the American Medical Association

P1476

Percutaneous left atrial appen ...... : a randomized clinical trial.

@en

P2093

Brian Whisenant

http://www.w3.org/2001/XMLSchema#string

David Holmes

http://www.w3.org/2001/XMLSchema#string

Horst Sievert

http://www.w3.org/2001/XMLSchema#string

Kenneth Huber

http://www.w3.org/2001/XMLSchema#string

Maurice Buchbinder

http://www.w3.org/2001/XMLSchema#string

Nicole Gordon

http://www.w3.org/2001/XMLSchema#string

PROTECT AF Steering Committee and Investigators

http://www.w3.org/2001/XMLSchema#string

Petr Neuzil

http://www.w3.org/2001/XMLSchema#string

Saibal Kar

http://www.w3.org/2001/XMLSchema#string

Shephal K Doshi

http://www.w3.org/2001/XMLSchema#string

P304

1988-1998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2014.15192

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

312

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan L. Halperin

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25399274

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation